* Says unit plans to joint conduct randomized controlled trial related to sarcopenia prevention of stomach cancer perioperative period with partner, from Sept. 1 Sign up here. Technologycategory ...
Tonix Pharmaceuticals (TNXP) announced plans to progress its TNX-2900 program for the treatment of Prader-Willi syndrome into a Phase 2 clinical ...
VIENNA — Tirzepatide was associated with improvements in body weight and body composition, and with lower insulin doses, in the first-ever randomized controlled trial (RCT) of the drug in people with ...
Idiopathic normal-pressure hydrocephalus is a neurologic disorder characterized by impaired gait, balance, cognition, and bladder control in older adults. The disorder is treated with shunt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback